{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:34:43Z","timestamp":1793003683135,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048892"],"award-info":[{"award-number":["R01DA048892"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40265-026-02364-4","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:25:36Z","timestamp":1791138336000},"page":"1841-1856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infections and the Opioid Epidemic: Changing Epidemiology and Treatment Options"],"prefix":"10.1007","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0582-2399","authenticated-orcid":false,"given":"Laura C.","family":"Fanucchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Van Sickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,4]]},"reference":[{"issue":"25","key":"2364_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","volume":"73","author":"D Dowell","year":"2022","unstructured":"Dowell D, Brown S, Gyawali S, Hoenig J, Ko J, Mikosz C, et al. Treatment for opioid use disorder: population estimates - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;73(25):567\u201374. https:\/\/doi.org\/10.15585\/mmwr.mm7325a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2364_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jama.2024.11977","volume":"332","author":"MA Arwady","year":"2024","unstructured":"Arwady MA, Delphin-Rittmon M, Volkow ND. Major gaps in the cascade of care for opioid use disorder: implications for clinical practice. JAMA. 2024;332(9):701\u20132. https:\/\/doi.org\/10.1001\/jama.2024.11977.","journal-title":"JAMA"},{"key":"2364_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ (Clinical research ed). 2017;357:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ (Clinical research ed)."},{"issue":"5","key":"2364_CR4","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","volume":"11","author":"S Colledge-Frisby","year":"2023","unstructured":"Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB, et al. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e673\u201383. https:\/\/doi.org\/10.1016\/S2214-109X(23)00058-X.","journal-title":"Lancet Glob Health"},{"key":"2364_CR5","unstructured":"World Health Organization, 2025. https:\/\/list.essentialmeds.org\/. Accessed 2 Sep 2025."},{"issue":"11","key":"2364_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242165","volume":"15","author":"J Capizzi","year":"2008","unstructured":"Capizzi J, Leahy J, Wheelock H, Garcia J, Strnad L, Sikka M, et al. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLoS ONE. 2008;15(11):e0242165.","journal-title":"PLoS ONE"},{"issue":"7","key":"2364_CR7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/cid\/ciy632","volume":"68","author":"AC Miller","year":"2019","unstructured":"Miller AC, Polgreen PM. Many opportunities to record, diagnose, or treat injection drug\u2013related infections are missed: a population-based cohort study of inpatient and emergency department settings. Clin Infect Dis. 2019;68(7):1166\u201375.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2364_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/14659891.2019.1572805","volume":"24","author":"M Moradi-Joo","year":"2019","unstructured":"Moradi-Joo M, Ghiasvand H, Noroozi M, Armoon B, Noroozi A, Karimy M, et al. Prevalence of skin and soft tissue infections and its related high-risk behaviors among people who inject drugs: a systematic review and meta-analysis. J Subst Use. 2019;24(4):350\u201360.","journal-title":"J Subst Use"},{"issue":"5","key":"2364_CR9","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/hsc.13559","volume":"30","author":"JE Ozga","year":"2022","unstructured":"Ozga JE, Syvertsen JL, Zweifler JA, Pollini RA. A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States. Health Soc Care Community. 2022;30(5):1798\u2013808.","journal-title":"Health Soc Care Community"},{"key":"2364_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.029.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2364_CR11","first-page":"595","volume":"107","author":"D Vlahov","year":"1992","unstructured":"Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992;107(5):595.","journal-title":"Public Health Rep"},{"issue":"6","key":"2364_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129360","volume":"10","author":"H Tookes","year":"2015","unstructured":"Tookes H, Diaz C, Li H, Khalid R, Doblecki-Lewis S. A cost analysis of hospitalizations for infections related to injection drug use at a county safety-net hospital in Miami, Florida. PLoS ONE. 2015;10(6):e0129360.","journal-title":"PLoS ONE"},{"key":"2364_CR13","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6622a1","author":"AT Fleischauer","year":"2010","unstructured":"Fleischauer AT. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence\u2014North Carolina, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2010. https:\/\/doi.org\/10.15585\/mmwr.mm6622a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2364_CR14","doi-asserted-by":"crossref","unstructured":"Wurcel AG, Anderson JE, Chui KK, Skinner S, Knox TA, Snydman DR, et al. Increasing infectious endocarditis admissions among young people who inject drugs. In: Open forum infectious diseases: Oxford University Press; 2016, p. ofw157.","DOI":"10.1093\/ofid\/ofw157"},{"issue":"S1","key":"2364_CR15","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.2105\/ajph.2021.306680","volume":"112","author":"HLF Cooper","year":"2022","unstructured":"Cooper HLF, Cloud DH, Fanucchi LC, Lofwall M, Young AM. Dismantling war on drugs policies in COVID-19\u2019s aftermath. Am J Public Health. 2022;112(S1):S24\u20137. https:\/\/doi.org\/10.2105\/ajph.2021.306680.","journal-title":"Am J Public Health"},{"issue":"10050","key":"2364_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/s0140-6736(16)30856-x","volume":"388","author":"FL Altice","year":"2016","unstructured":"Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016;388(10050):1228\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(16)30856-x.","journal-title":"Lancet"},{"issue":"8","key":"2364_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/s2215-0366(22)00159-6","volume":"9","author":"V Haldane","year":"2022","unstructured":"Haldane V, Jung AS, De Foo C, Shrestha P, Urdaneta E, Turk E, et al. Integrating HIV and substance misuse services: a person-centred approach grounded in human rights. Lancet Psychiatry. 2022;9(8):676\u201388. https:\/\/doi.org\/10.1016\/s2215-0366(22)00159-6.","journal-title":"Lancet Psychiatry"},{"key":"2364_CR18","unstructured":"Williams AR, Nunes EV, Olfson M. To battle the opioid overdose epidemic, deploy the 'Cascade of Care' Model. Health Affairs Blog."},{"issue":"12","key":"2364_CR19","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/add.13479","volume":"111","author":"ME Socias","year":"2016","unstructured":"Socias ME, Volkow N, Wood E. Adopting the \u201ccascade of care\u201d framework: an opportunity to close the implementation gap in addiction care? Addiction (Abingdon, England). 2016;111(12):2079\u201381. https:\/\/doi.org\/10.1111\/add.13479.","journal-title":"Addiction (Abingdon, England)"},{"key":"2364_CR20","unstructured":"HIV.gov. HIV Care Continuum. 2025."},{"key":"2364_CR21","unstructured":"Prevention CfDCa. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report2021."},{"key":"2364_CR22","unstructured":"Organization WH. Fact Sheets: HIV and AIDS. 2025."},{"issue":"10","key":"2364_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa414","volume":"7","author":"LR Marks","year":"2020","unstructured":"Marks LR, Nolan NS, Jiang L, Muthulingam D, Liang SY, Durkin MJ. Use of ICD-10 codes for identification of injection drug use-associated infective endocarditis is nonspecific and obscures critical findings on impact of medications for opioid use disorder. Open Forum Infect Dis. 2020;7(10):ofaa414. https:\/\/doi.org\/10.1093\/ofid\/ofaa414.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"2364_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1473-3099(16)30325-5","volume":"16","author":"L Degenhardt","year":"2016","unstructured":"Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385\u201398. https:\/\/doi.org\/10.1016\/S1473-3099(16)30325-5.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2364_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323\u201331. https:\/\/doi.org\/10.1097\/QAI.0000000000001098.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2364_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","volume":"76","author":"H Bradley","year":"2023","unstructured":"Bradley H, Hall EW, Asher A, Furukawa NW, Jones CM, Shealey J, et al. Estimated number of people who inject drugs in the United States. Clin Infect Dis. 2023;76(1):96\u2013102. https:\/\/doi.org\/10.1093\/cid\/ciac543.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2364_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097596","volume":"9","author":"A Lansky","year":"2014","unstructured":"Lansky A, Finlayson T, Johnson C, Holtzman D, Wejnert C, Mitsch A, et al. Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS ONE. 2014;9(5):e97596. https:\/\/doi.org\/10.1371\/journal.pone.0097596.","journal-title":"PLoS ONE"},{"issue":"6","key":"2364_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","volume":"73","author":"LJ Tanz","year":"2020","unstructured":"Tanz LJ, Gladden RM, Dinwiddie AT, Miller KD, Broz D, Spector E, et al. Routes of drug use among drug overdose deaths - United States, 2020-2022. MMWR Morb Mortal Wkly Rep. 2020;73(6):124\u201330. https:\/\/doi.org\/10.15585\/mmwr.mm7306a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"2364_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.15585\/mmwr.mm7350a4","volume":"73","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jiang X, Gladden RM, Nataraj N, Guy GP Jr., Dowell D. Notes from the field: geo-temporal trends in fentanyl administration routes among adults reporting use of illegally manufactured fentanyl when assessed for substance-use treatment - 14 U.S. states, 2017-2023. MMWR Morb Mortal Wkly Rep. 2024;73(50):1147\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7350a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2364_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.mcna.2021.08.006","volume":"106","author":"LR Marks","year":"2022","unstructured":"Marks LR, Nolan NS, Liang SY, Durkin MJ, Weimer MB. Infectious complications of injection drug use. Med Clin North Am. 2022;106(1):187\u2013200. https:\/\/doi.org\/10.1016\/j.mcna.2021.08.006.","journal-title":"Med Clin North Am"},{"key":"2364_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104422","volume":"128","author":"T Jahangir","year":"2024","unstructured":"Jahangir T, Fuller GK, Livingston MD, Freeman E, Fanucchi LC, Fallin-Bennett A, et al. Syringe reuse among people who inject drugs in rural Appalachian Kentucky. Int J Drug Policy. 2024;128:104422. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104422.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"2364_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-021-00524-1","volume":"18","author":"K Thakarar","year":"2021","unstructured":"Thakarar K, Sankar N, Murray K, Lucas FL, Burris D, Smith RP. Injections and infections: understanding syringe service program utilization in a rural state. Harm Reduct J. 2021;18(1):74. https:\/\/doi.org\/10.1186\/s12954-021-00524-1.","journal-title":"Harm Reduct J"},{"issue":"3","key":"2364_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ajic.2012.04.330","volume":"41","author":"DL Johnson","year":"2013","unstructured":"Johnson DL, Mead KR, Lynch RA, Hirst DV. Lifting the lid on toilet plume aerosol: a literature review with suggestions for future research. Am J Infect Control. 2013;41(3):254\u20138. https:\/\/doi.org\/10.1016\/j.ajic.2012.04.330.","journal-title":"Am J Infect Control"},{"issue":"5152","key":"2364_CR34","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.15585\/mmwr.mm675152a3","volume":"67","author":"CM Peak","year":"2017","unstructured":"Peak CM, Rosen H, Kamali A, Poe A, Shahkarami M, Kimura AC, et al. Wound botulism outbreak among persons who use black tar heroin - San Diego County, California, 2017-2018. MMWR Morb Mortal Wkly Rep. 2017;67(5152):1415\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm675152a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2364_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3201\/eid1901.120044","volume":"19","author":"NE Palmateer","year":"2000","unstructured":"Palmateer NE, Hope VD, Roy K, Marongiu A, White JM, Grant KA, et al. Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis. 2000;19(1):29\u201334. https:\/\/doi.org\/10.3201\/eid1901.120044.","journal-title":"Emerg Infect Dis"},{"issue":"2\u20133","key":"2364_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","volume":"89","author":"RN Bluthenthal","year":"2007","unstructured":"Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2\u20133):214\u201322. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.12.035.","journal-title":"Drug Alcohol Depend"},{"key":"2364_CR37","unstructured":"Syringe Services Programs: Summary of State Laws. Legislative Analysis and Public Policy Association: Legislative Analysis and Public Policy Association; 2025."},{"issue":"10","key":"2364_CR38","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1176\/appi.ps.201400140","volume":"65","author":"CL Barry","year":"2014","unstructured":"Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv. 2014;65(10):1269\u201372.","journal-title":"Psychiatr Serv"},{"issue":"7","key":"2364_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3109\/10826084.2013.787094","volume":"48","author":"DS Fink","year":"2013","unstructured":"Fink DS, Lindsay SP, Slymen DJ, Kral AH, Bluthenthal RN. Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities. Subst Use Misuse. 2013;48(7):523\u201331.","journal-title":"Subst Use Misuse"},{"key":"2364_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107695","volume":"206","author":"J Monteiro","year":"2020","unstructured":"Monteiro J, Phillips KT, Herman DS, Stewart C, Keosaian J, Anderson BJ, et al. Self-treatment of skin infections by people who inject drugs. Drug Alcohol Depend. 2020;206:107695.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2364_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/00952991003592311","volume":"36","author":"KT Phillips","year":"2010","unstructured":"Phillips KT, Stein MD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. Am J Drug Alcohol Abuse. 2010;36(2):92\u20137.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"2364_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1086\/313703","volume":"30","author":"IA Binswanger","year":"2000","unstructured":"Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30(3):579\u201381.","journal-title":"Clin Infect Dis"},{"key":"2364_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s11606-006-0079-y","volume":"22","author":"TA Takahashi","year":"2007","unstructured":"Takahashi TA, Baernstein A, Binswanger I, Bradley K, Merrill JO. Predictors of hospitalization for injection drug users seeking care for soft tissue infections. J Gen Intern Med. 2007;22:382\u20138.","journal-title":"J Gen Intern Med"},{"key":"2364_CR44","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.ijid.2010.02.2238","volume":"14","author":"RA Pollini","year":"2010","unstructured":"Pollini RA, Gallardo M, Hasan S, Minuto J, Lozada R, Vera A, et al. High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. Int J Infect Dis. 2010;14:e117\u201322.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2364_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amepre.2022.07.011","volume":"64","author":"MS Ellis","year":"2023","unstructured":"Ellis MS, Kasper ZA, Takenaka B, Buttram ME, Shacham E. Associations of transactional sex and sexually transmitted infections among treatment-seeking individuals with opioid use disorder. Am J Prev Med. 2023;64(1):17\u201325. https:\/\/doi.org\/10.1016\/j.amepre.2022.07.011.","journal-title":"Am J Prev Med"},{"issue":"8","key":"2364_CR46","doi-asserted-by":"publisher","first-page":"e2330225","DOI":"10.1001\/jamanetworkopen.2023.30225","volume":"6","author":"WD Jenkins","year":"2023","unstructured":"Jenkins WD, Friedman SR, Hurt CB, Korthuis PT, Feinberg J, Del Toro-Mejias LM, et al. Variation in HIV transmission behaviors among people who use drugs in rural US communities. JAMA Netw Open. 2023;6(8):e2330225. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.30225.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2364_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4326-3","volume":"19","author":"RC Berg","year":"2019","unstructured":"Berg RC, Weatherburn P, Marcus U, Schmidt AJ. Links between transactional sex and HIV\/STI-risk and substance use among a large sample of European men who have sex with men. BMC Infect Dis. 2019;19(1):686. https:\/\/doi.org\/10.1186\/s12879-019-4326-3.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"2364_CR48","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","volume":"18","author":"J Stone","year":"2018","unstructured":"Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(12):1397\u2013409. https:\/\/doi.org\/10.1016\/S1473-3099(18)30469-9.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2364_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/15504263.2018.1510148","volume":"14","author":"M Kidorf","year":"2018","unstructured":"Kidorf M, Solazzo S, Yan H, Brooner RK. Psychiatric and substance use comorbidity in treatment-seeking injection opioid users referred from syringe exchange. J Dual Diagn. 2018;14(4):193\u2013200. https:\/\/doi.org\/10.1080\/15504263.2018.1510148.","journal-title":"J Dual Diagn"},{"key":"2364_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109551","volume":"238","author":"T Santo Jr.","year":"2022","unstructured":"Santo T Jr., Campbell G, Gisev N, Martino-Burke D, Wilson J, Colledge-Frisby S, et al. Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis. Drug Alcohol Depend. 2022;238:109551. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109551.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2364_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00127-021-02199-2","volume":"57","author":"J van Draanen","year":"2022","unstructured":"van Draanen J, Tsang C, Mitra S, Phuong V, Murakami A, Karamouzian M, et al. Mental disorder and opioid overdose: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2022;57(4):647\u201371. https:\/\/doi.org\/10.1007\/s00127-021-02199-2.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2364_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108041","volume":"212","author":"RE Gicquelais","year":"2020","unstructured":"Gicquelais RE, Jannausch M, Bohnert ASB, Thomas L, Sen S, Fernandez AC. Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose. Drug Alcohol Depend. 2020;212:108041. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108041.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"2364_CR53","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/add.13788","volume":"112","author":"MLD \u00d8stergaard","year":"2017","unstructured":"\u00d8stergaard MLD, Nordentoft M, Hjorth\u00f8j C. Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder. Addiction (Abingdon, England). 2017;112(7):1250\u20139. https:\/\/doi.org\/10.1111\/add.13788.","journal-title":"Addiction (Abingdon, England)"},{"issue":"1-2","key":"2364_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2010.11.003","volume":"115","author":"JR Havens","year":"2011","unstructured":"Havens JR, Oser CB, Knudsen HK, Lofwall M, Stoops WW, Walsh SL, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011;115(1\u20132):107\u201312. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.11.003.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2364_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11524-006-9144-4","volume":"84","author":"JR Havens","year":"2007","unstructured":"Havens JR, Cornelius LJ, Ricketts EP, Latkin CA, Bishai D, Lloyd JJ, et al. The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder. J Urban Health. 2007;84(2):267\u201371. https:\/\/doi.org\/10.1007\/s11524-006-9144-4.","journal-title":"J Urban Health"},{"issue":"1","key":"2364_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12954-020-00396-x","volume":"17","author":"KA Morin","year":"2020","unstructured":"Morin KA, Eibl JK, Gauthier G, Rush B, Mushquash C, Lightfoot NE, et al. A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data. Harm Reduct J. 2020;17(1):51. https:\/\/doi.org\/10.1186\/s12954-020-00396-x.","journal-title":"Harm Reduct J"},{"key":"2364_CR57","unstructured":"Substance Abuse and Mental Health Services Administration: Practical Guide for Implementing a Trauma-Informed Approach. National Mental Health and Substance Use Policy Laboratory. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2023."},{"key":"2364_CR58","doi-asserted-by":"publisher","first-page":"204993612211080","DOI":"10.1177\/20499361221108005","volume":"9","author":"LC Fanucchi","year":"2022","unstructured":"Fanucchi LC, Murphy SM, Surratt H, Kapadia SN, Walsh SL, Grubbs JA, et al. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections. Ther Adv Infect Dis. 2022;9:20499361221108004. https:\/\/doi.org\/10.1177\/20499361221108005.","journal-title":"Ther Adv Infect Dis."},{"key":"2364_CR59","volume-title":"Treating traumatic stress and substance misuse: a guide to integrative practice","author":"D Hien","year":"2024","unstructured":"Hien D, Litt LC. Treating traumatic stress and substance misuse: a guide to integrative practice. New York, NY: Guildford Press; 2024."},{"key":"2364_CR60","doi-asserted-by":"publisher","DOI":"10.3402\/ejpt.v4i0.20706","author":"M Cloitre","year":"2013","unstructured":"Cloitre M, Garvert DW, Brewin CR, Bryant RA, Maercker A. Evidence for proposed ICD-11 PTSD and complex PTSD: a latent profile analysis. Eur J Psychotraumatol. 2013. https:\/\/doi.org\/10.3402\/ejpt.v4i0.20706.","journal-title":"Eur J Psychotraumatol"},{"issue":"3","key":"2364_CR61","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wps.20057","volume":"12","author":"A Maercker","year":"2013","unstructured":"Maercker A, Brewin CR, Bryant RA, Cloitre M, van Ommeren M, Jones LM, et al. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry. 2013;12(3):198\u2013206. https:\/\/doi.org\/10.1002\/wps.20057.","journal-title":"World Psychiatry"},{"issue":"16","key":"2364_CR62","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/nejm197804202981605","volume":"298","author":"JE Groves","year":"1978","unstructured":"Groves JE. Taking care of the hateful patient. N Engl J Med. 1978;298(16):883\u20137. https:\/\/doi.org\/10.1056\/nejm197804202981605.","journal-title":"N Engl J Med"},{"issue":"2","key":"2364_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jama.2025.6554","volume":"334","author":"MR Gerber","year":"2025","unstructured":"Gerber MR, Adger Antonikowski A. Trauma-informed care. JAMA. 2025;334(2):173\u20134. https:\/\/doi.org\/10.1001\/jama.2025.6554.","journal-title":"JAMA"},{"key":"2364_CR64","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jss.2024.01.042","volume":"296","author":"B Chin","year":"2024","unstructured":"Chin B, Amin Q, Hernandez N, Wright DD, Awan MU, Plumley D, et al. Evaluating the effectiveness of trauma-informed care frameworks in provider education and the care of traumatized patients. J Surg Res. 2024;296:621\u201335. https:\/\/doi.org\/10.1016\/j.jss.2024.01.042.","journal-title":"J Surg Res"},{"key":"2364_CR65","doi-asserted-by":"crossref","unstructured":"Rosenthal ES CJ, Brokus CJ, Carpenter J, Eaton E, Eaton E, Kuo I, Steck A, Akselrod H, Burgan KW, Burkholder GA, McGonigle K, Mai W, Notis M, Sun J, Kattakuzhy S. No source control: low rates of medication for opioid use disorder in individuals hospitalized with infectious complications of injection opioid use at four academic medical centers. IDWeek: Open Forum Infectious Diseases; 2021. p. 408\u20139.","DOI":"10.1093\/ofid\/ofab466.809"},{"issue":"10","key":"2364_CR66","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/cid\/ciaa372","volume":"72","author":"CY Wong","year":"2007","unstructured":"Wong CY, Zhu W, Aurigemma GP, Furukawa N, Teshale EH, Huang Y-lA, et al. Infective endocarditis among persons aged 18\u201364 years living with human immunodeficiency virus, hepatitis C infection, or opioid use disorder, United States, 2007\u22122017. Clin Infect Dis. 2007;72(10):1767\u201381. https:\/\/doi.org\/10.1093\/cid\/ciaa372.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2364_CR67","doi-asserted-by":"publisher","first-page":"e3661","DOI":"10.1093\/cid\/ciaa1346","volume":"73","author":"JA Barocas","year":"2021","unstructured":"Barocas JA, Eftekhari Yazdi G, Savinkina A, Nolen S, Savitzky C, Samet JH, et al. Long-term infective endocarditis mortality associated with injection opioid use in the United States: a modeling study. Clin Infect Dis. 2021;73(11):e3661\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaa1346.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2364_CR68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/29767342231214472","volume":"45","author":"JJ Carroll","year":"2024","unstructured":"Carroll JJ. Xylazine-associated wounds and related health concerns among people who use drugs: reports from front-line health workers in 7 US states. Subst Use Addict J. 2024;45(2):222\u201331. https:\/\/doi.org\/10.1177\/29767342231214472.","journal-title":"Subst Use Addict J"},{"key":"2364_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111702","volume":"267","author":"W Bradford","year":"2025","unstructured":"Bradford W, Figgatt M, Scott K, Marshall S, Eaton E, Dye D. Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data. Drug Alcohol Depend. 2025;267:111702.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2364_CR70","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s2468-1253(23)00018-3","volume":"8","author":"A Artenie","year":"2023","unstructured":"Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, et al. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):533\u201352. https:\/\/doi.org\/10.1016\/s2468-1253(23)00018-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2364_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2025.209693","volume":"173","author":"A Khati","year":"2025","unstructured":"Khati A, Copenhaver M, Xu R, Altice FL, Wickersham JA, Gautam K, et al. Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention. J Subst Use Addict Treat. 2025;173:209693. https:\/\/doi.org\/10.1016\/j.josat.2025.209693.","journal-title":"J Subst Use Addict Treat"},{"key":"2364_CR72","volume-title":"HIV PrEP for people who inject drugs","author":"NHP Curriculum","year":"2025","unstructured":"Curriculum NHP. HIV PrEP for people who inject drugs. University of Washington; 2025."},{"issue":"6","key":"2364_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jvh.13933","volume":"31","author":"JR Havens","year":"2024","unstructured":"Havens JR, Lofwall MR, Young AM, Staton M, Schaninger T, Fraser H, et al. Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community. J Viral Hepat. 2024;31(6):293\u20139. https:\/\/doi.org\/10.1111\/jvh.13933.","journal-title":"J Viral Hepat"},{"issue":"11","key":"2364_CR74","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","volume":"3","author":"B Hajarizadeh","year":"2018","unstructured":"Hajarizadeh B, Cunningham EB, Reid H, Law M, Dore GJ, Grebely J. Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2018;3(11):754\u201367. https:\/\/doi.org\/10.1016\/S2468-1253(18)30304-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2364_CR75","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jhep.2019.11.012","volume":"72","author":"B Hajarizadeh","year":"2020","unstructured":"Hajarizadeh B, Cunningham EB, Valerio H, Martinello M, Law M, Janjua NZ, et al. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis. J Hepatol. 2020;72(4):643\u201357. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.012.","journal-title":"J Hepatol"},{"issue":"3","key":"2364_CR76","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/cid\/ciad711","volume":"78","author":"H Midgard","year":"2024","unstructured":"Midgard H, Malme KB, Pihl CM, Berg-Pedersen RM, Tanum L, Klundby I, et al. Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): a stepped wedge cluster randomized trial. Clin Infect Dis. 2024;78(3):582\u201390. https:\/\/doi.org\/10.1093\/cid\/ciad711.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2364_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf237","volume":"12","author":"J Denkins","year":"2025","unstructured":"Denkins J, Babiarz J, Ham Y, Ryu H, Ricci B, Williams C, et al. Hepatitis C treatment initiation during hospitalization for people who use drugs: a narrative review of the literature. Open Forum Infect Dis. 2025;12(6):ofaf237. https:\/\/doi.org\/10.1093\/ofid\/ofaf237.","journal-title":"Open Forum Infect Dis"},{"key":"2364_CR78","unstructured":"US Department of Health and Human Services: Viral Hepatitis National Strategic Plan. (2025). https:\/\/www.hhs.gov\/hepatitis\/viral-hepatitis-national-strategic-plan\/index.html. Accessed 23 Sep 2025."},{"issue":"4","key":"2364_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf211","volume":"12","author":"T Yoder","year":"2025","unstructured":"Yoder T, Hirose K, Tsui JI, Feinberg J, Hagan H, Pho MT, et al. Approaches to offering hepatitis C treatment at syringe services programs in the United States: a scoping review. Open Forum Infect Dis. 2025;12(4):ofaf211. https:\/\/doi.org\/10.1093\/ofid\/ofaf211.","journal-title":"Open Forum Infect Dis"},{"key":"2364_CR80","unstructured":"Diseases AAftSoL, Infectious Diseases Society of A. Simplified HCV treatment* for treatment-naive adults without cirrhosis. 2023."},{"issue":"3","key":"2364_CR81","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/ADM.0000000000000730","volume":"15","author":"DA Oller","year":"2021","unstructured":"Oller DA, Thornton C, Nuzzo PA, Fanucchi LC. Buprenorphine induction in persons with opioid use disorder hospitalized with acute hepatitis A. J Addict Med. 2021;15(3):187\u201390. https:\/\/doi.org\/10.1097\/ADM.0000000000000730.","journal-title":"J Addict Med"},{"key":"2364_CR82","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.20.0190","author":"G D\u2019Onofrio","year":"2020","unstructured":"D\u2019Onofrio G, Venkatesh A, Hawk K. The adverse impact of Covid-19 on individuals with OUD highlights the urgent need for reform to leverage emergency department-based treatment. Catalyst Non-issue Content. 2020. https:\/\/doi.org\/10.1056\/CAT.20.0190.","journal-title":"Catalyst Non-issue Content."},{"issue":"3","key":"2364_CR83","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1037\/tra0001431","volume":"16","author":"KE Silver","year":"2024","unstructured":"Silver KE, Norton M, King K, Gonzalez A, Holmes SC, Johnson DM. Survival sex among a diverse sample of women with histories of intimate partner violence: results from a domestic violence shelter. Psychol Trauma. 2024;16(3):454\u201361. https:\/\/doi.org\/10.1037\/tra0001431.","journal-title":"Psychol Trauma"},{"key":"2364_CR84","doi-asserted-by":"publisher","DOI":"10.1177\/21501319241285531","volume":"15","author":"AW Fujita","year":"2024","unstructured":"Fujita AW, Ramakrishnan A, Mehta CC, Yusuf OB, Thompson AB, Shoptaw S, et al. Co-utilization of HIV, substance use, mental health services among women with current substance use: opportunities for integrated care? J Prim Care Community Health. 2024;15:21501319241285531. https:\/\/doi.org\/10.1177\/21501319241285531.","journal-title":"J Prim Care Community Health"},{"key":"2364_CR85","unstructured":"World Health Organization implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. 2024."},{"issue":"2","key":"2364_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","volume":"73","author":"LH Bachmann","year":"2024","unstructured":"Bachmann LH, Barbee LA, Chan P, Reno H, Workowski KA, Hoover K, et al. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recomm Rep. 2024;73(2):1\u20138. https:\/\/doi.org\/10.15585\/mmwr.rr7302a1.","journal-title":"MMWR Recomm Rep"},{"key":"2364_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112795","volume":"275","author":"TJ Winhusen","year":"2025","unstructured":"Winhusen TJ, Kropp F, Smid MC, Young JL, Davies TH, Lewis D, et al. Personally-tailored opioid-overdose and medication for opioid use disorder (MOUD) education (TOME) significantly increases MOUD and overdose knowledge in peripartum individuals: results from a randomized controlled pilot trial. Drug Alcohol Depend. 2025;275:112795. https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112795.","journal-title":"Drug Alcohol Depend"},{"key":"2364_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104867","volume":"143","author":"KH Gelberg","year":"2025","unstructured":"Gelberg KH, El-Bassel N, Babineau DC, Vickers-Smith RA, Fanucchi LC, Childerhose JE, et al. Association of fentanyl test strip results and change in drug use behaviors: a multi-state, community-based observational study. Int J Drug Policy. 2025;143:104867. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104867.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"2364_CR89","doi-asserted-by":"publisher","first-page":"e2510077","DOI":"10.1001\/jamanetworkopen.2025.10077","volume":"8","author":"RA Vickers-Smith","year":"2025","unstructured":"Vickers-Smith RA, Gelberg KH, Childerhose JE, Babineau DC, Chandler R, David JL, et al. Fentanyl test strip use and overdose risk reduction behaviors among people who use drugs. JAMA Netw Open. 2025;8(5):e2510077. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.10077.","journal-title":"JAMA Netw Open"},{"key":"2364_CR90","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001550","author":"KH Gelberg","year":"2025","unstructured":"Gelberg KH, Montero F, Chang M, Russo MR, Lootens MR, David JL, et al. Xylazine test strip use among people who use drugs in New York State. J Addict Med. 2025. https:\/\/doi.org\/10.1097\/ADM.0000000000001550.","journal-title":"J Addict Med"},{"key":"2364_CR91","volume-title":"Integrating health services brief. Technical series on primary health care","author":"WH Organization","year":"2018","unstructured":"Organization WH. Integrating health services brief. Technical series on primary health care. World Health Organization; 2018."},{"issue":"7","key":"2364_CR92","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5055\/jom.2023.0799","volume":"19","author":"AM South","year":"2023","unstructured":"South AM, Fanucchi L, Lofwall M. Advocacy for patients with opioid use disorder: A primer for physicians and other clinicians on the Americans with Disabilities Act. J Opioid Manag. 2023;19(7):53\u201360. https:\/\/doi.org\/10.5055\/jom.2023.0799.","journal-title":"J Opioid Manag"},{"key":"2364_CR93","unstructured":"Center LA. Legal Action Center MAT\/MOUD Advocacy Toolkit. Legal Action Center; 2022."},{"issue":"1","key":"2364_CR94","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21585","volume":"20","author":"V Haldane","year":"2017","unstructured":"Haldane V, Cervero-Liceras F, Chuah FL, Ong SE, Murphy G, Sigfrid L, et al. Integrating HIV and substance use services: a systematic review. J Int AIDS Soc. 2017;20(1):21585. https:\/\/doi.org\/10.7448\/IAS.20.1.21585.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"2364_CR95","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/QAD.0000000000002125","volume":"33","author":"BJ Oldfield","year":"2019","unstructured":"Oldfield BJ, Munoz N, McGovern MP, Funaro M, Villanueva M, Tetrault JM, et al. Integration of care for HIV and opioid use disorder. AIDS. 2019;33(5):873\u201384. https:\/\/doi.org\/10.1097\/QAD.0000000000002125.","journal-title":"AIDS"},{"issue":"16","key":"2364_CR96","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jama.2024.2452","volume":"331","author":"AH Talal","year":"2024","unstructured":"Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, et al. Integrated hepatitis C-opioid use disorder care through facilitated telemedicine: a randomized trial. JAMA. 2024;331(16):1369\u201378. https:\/\/doi.org\/10.1001\/jama.2024.2452.","journal-title":"JAMA"},{"issue":"1","key":"2364_CR97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12954-023-00743-8","volume":"20","author":"M Di Ciaccio","year":"2023","unstructured":"Di Ciaccio M, Villes V, Perfect C, El Kaim JL, Donatelli M, James C, et al. Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey. Harm Reduct J. 2023;20(1):15. https:\/\/doi.org\/10.1186\/s12954-023-00743-8.","journal-title":"Harm Reduct J"},{"key":"2364_CR98","doi-asserted-by":"publisher","first-page":"1154813","DOI":"10.3389\/fpubh.2023.1154813","volume":"11","author":"MD Pepin","year":"2023","unstructured":"Pepin MD, Joseph JK, Chapman BP, McAuliffe C, O\u2019Donnell LK, Marano RL, et al. A mobile addiction service for community-based overdose prevention. Front Public Health. 2023;11:1154813. https:\/\/doi.org\/10.3389\/fpubh.2023.1154813.","journal-title":"Front Public Health"},{"issue":"5","key":"2364_CR99","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1001\/jamainternmed.2022.0170","volume":"182","author":"B Eckhardt","year":"2022","unstructured":"Eckhardt B, Mateu-Gelabert P, Aponte-Melendez Y, Fong C, Kapadia S, Smith M, et al. Accessible hepatitis C care for people who inject drugs: a randomized clinical trial. JAMA Intern Med. 2022;182(5):494\u2013502. https:\/\/doi.org\/10.1001\/jamainternmed.2022.0170.","journal-title":"JAMA Intern Med"},{"key":"2364_CR100","doi-asserted-by":"publisher","first-page":"204993612513147","DOI":"10.1177\/20499361251314766","volume":"12","author":"HL Surratt","year":"2025","unstructured":"Surratt HL, Brown S, Burton AL, Cranford W, Fanucchi LC, Green C, et al. Outcomes of a pilot randomized clinical trial testing brief interventions to increase HIV pre-exposure prophylaxis uptake among rural people who inject drugs attending syringe services programs. Ther Adv Infect Dis. 2025;12:20499361251314770. https:\/\/doi.org\/10.1177\/20499361251314766.","journal-title":"Ther Adv Infect Dis."},{"key":"2364_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2019.05.003","volume":"103","author":"C Peterson","year":"2019","unstructured":"Peterson C, Xu L, Florence C, Mack KA. Opioid-related US hospital discharges by type, 1993-2016. J Subst Abuse Treat. 2019;103:9\u201313. https:\/\/doi.org\/10.1016\/j.jsat.2019.05.003.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"2364_CR102","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.athoracsur.2020.03.089","volume":"110","author":"A Geirsson","year":"2020","unstructured":"Geirsson A, Schranz A, Jawitz O, Mori M, Feng L, Zwischenberger BA, et al. The evolving burden of drug use associated infective endocarditis in the United States. Ann Thorac Surg. 2020;110(4):1185\u201392. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.03.089.","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 5","key":"2364_CR103","doi-asserted-by":"publisher","first-page":"S458","DOI":"10.1093\/infdis\/jiaa129","volume":"222","author":"M Sredl","year":"2020","unstructured":"Sredl M, Fleischauer AT, Moore Z, Rosen DL, Schranz AJ. Not just endocarditis: hospitalizations for selected invasive infections among persons with opioid and stimulant use diagnoses-North Carolina, 2010-2018. J Infect Dis. 2020;222(Suppl 5):S458\u201364. https:\/\/doi.org\/10.1093\/infdis\/jiaa129.","journal-title":"J Infect Dis"},{"issue":"2","key":"2364_CR104","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0733-8651(03)00025-0","volume":"21","author":"JM Miro","year":"2003","unstructured":"Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21(2):167\u201384.","journal-title":"Cardiol Clin"},{"issue":"10021","key":"2364_CR105","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(15)00067-7","volume":"387","author":"TJ Cahill","year":"2016","unstructured":"Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(15)00067-7.","journal-title":"Lancet"},{"key":"2364_CR106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","volume":"92","author":"LC Fanucchi","year":"2018","unstructured":"Fanucchi LC, Lofwall MR, Nuzzo PA, Walsh SL. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs. J Subst Abuse Treat. 2018;92:64\u20139. https:\/\/doi.org\/10.1016\/j.jsat.2018.06.011.","journal-title":"J Subst Abuse Treat"},{"key":"2364_CR107","doi-asserted-by":"crossref","unstructured":"Jicha C, Saxon D, Lofwall MR, Fanucchi L. Substance use disorder assessment, diagnosis, and management for patients hospitalized with severe infections due to injection drug use. J Addict Med. 2018; (in press).","DOI":"10.1097\/ADM.0000000000000454"},{"key":"2364_CR108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsat.2019.04.008","volume":"102","author":"B Bearnot","year":"2019","unstructured":"Bearnot B, Mitton JA, Hayden M, Park ER. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: results from a qualitative study. J Subst Abuse Treat. 2019;102:16\u201322. https:\/\/doi.org\/10.1016\/j.jsat.2019.04.008.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"2364_CR109","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11606-022-07939-x","volume":"38","author":"H Englander","year":"2023","unstructured":"Englander H, Gregg J, Levander XA. Envisioning minimally disruptive opioid use disorder care. J Gen Intern Med. 2023;38(3):799\u2013803. https:\/\/doi.org\/10.1007\/s11606-022-07939-x.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"2364_CR110","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jhm.12893","volume":"17","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, et al. Management of opioid use disorder and associated conditions among hospitalized adults: a consensus statement from the Society of Hospital Medicine. J Hosp Med. 2022;17(9):744\u201356. https:\/\/doi.org\/10.1002\/jhm.12893.","journal-title":"J Hosp Med"},{"key":"2364_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209298","volume":"160","author":"NM Robertson","year":"2024","unstructured":"Robertson NM, Mangino AA, South AM, Fanucchi LC. Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: a matched cohort study. J Subst Use Addict Treat. 2024;160:209298. https:\/\/doi.org\/10.1016\/j.josat.2024.209298.","journal-title":"J Subst Use Addict Treat."},{"issue":"11","key":"2364_CR112","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s11606-022-07618-x","volume":"37","author":"H Englander","year":"2022","unstructured":"Englander H, Jones A, Krawczyk N, Patten A, Roberts T, Korthuis PT, et al. A taxonomy of hospital-based addiction care models: a scoping review and key informant interviews. J Gen Intern Med. 2022;37(11):2821\u201333. https:\/\/doi.org\/10.1007\/s11606-022-07618-x.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"2364_CR113","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/jamainternmed.2024.3422","volume":"184","author":"J McNeely","year":"2024","unstructured":"McNeely J, Wang SS, Rostam Abadi Y, Barron C, Billings J, Tarpey T, et al. Addiction consultation services for opioid use disorder treatment initiation and engagement: a randomized clinical trial. JAMA Intern Med. 2024;184(9):1106\u201315. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3422.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"2364_CR114","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad444","volume":"10","author":"AS Roy","year":"2023","unstructured":"Roy AS, Hagh-Doust H, Abdul Azim A, Caceres J, Denholm JT, Dong MQD, et al. Multidisciplinary teams for the management of infective endocarditis: a systematic review and meta-analysis. Open Forum Infect Dis. 2023;10(9):ofad444. https:\/\/doi.org\/10.1093\/ofid\/ofad444.","journal-title":"Open Forum Infect Dis"},{"key":"2364_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100031","volume":"2","author":"CD Nordeck","year":"2022","unstructured":"Nordeck CD, Welsh C, Schwartz RP, Mitchell SG, O\u2019Grady KE, Gryczynski J. Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug Alcohol Depend Rep. 2022;2:100031. https:\/\/doi.org\/10.1016\/j.dadr.2022.100031.","journal-title":"Drug Alcohol Depend Rep."},{"issue":"15","key":"2364_CR116","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435\u201386. https:\/\/doi.org\/10.1161\/CIR.0000000000000296.","journal-title":"Circulation"},{"issue":"6","key":"2364_CR117","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1093\/cid\/civ482","volume":"61","author":"EF Berbari","year":"2015","unstructured":"Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015;61(6):e26-46. https:\/\/doi.org\/10.1093\/cid\/civ482.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2364_CR118","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy745","volume":"68","author":"AH Norris","year":"2019","unstructured":"Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, et al. 2018 Infectious diseases society of america clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2019;68(1):e1\u201335. https:\/\/doi.org\/10.1093\/cid\/ciy745.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2364_CR119","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013560","volume":"7","author":"ED Mitchell","year":"2017","unstructured":"Mitchell ED, Czoski Murray C, Meads D, Minton J, Wright J, Twiddy M. Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open. 2017;7(4):e013560. https:\/\/doi.org\/10.1136\/bmjopen-2016-013560.","journal-title":"BMJ Open"},{"issue":"7","key":"2364_CR120","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejim.2013.03.014","volume":"24","author":"RA Seaton","year":"2013","unstructured":"Seaton RA, Barr DA. Outpatient parenteral antibiotic therapy: principles and practice. Eur J Intern Med. 2013;24(7):617\u201323. https:\/\/doi.org\/10.1016\/j.ejim.2013.03.014.","journal-title":"Eur J Intern Med"},{"key":"2364_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105760","volume":"128","author":"LC Fanucchi","year":"2019","unstructured":"Fanucchi LC, Walsh SL, Thornton AC, Lofwall MR. Integrated outpatient treatment of opioid use disorder and injection-related infections: a description of a new care model. Prev Med. 2019;128:105760. https:\/\/doi.org\/10.1016\/j.ypmed.2019.105760.","journal-title":"Prev Med"},{"issue":"6","key":"2364_CR122","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/cid\/ciz654","volume":"70","author":"LC Fanucchi","year":"2020","unstructured":"Fanucchi LC, Walsh SL, Thornton AC, Nuzzo PA, Lofwall MR. Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections. Clin Infect Dis. 2020;70(6):1226\u20139. https:\/\/doi.org\/10.1093\/cid\/ciz654.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2364_CR123","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/cid\/ciad119","volume":"77","author":"S Freling","year":"2023","unstructured":"Freling S, Wald-Dickler N, Banerjee J, Canamar CP, Tangpraphaphorn S, Bruce D, et al. Real-world application of oral therapy for infective endocarditis: a multicenter, retrospective, cohort study. Clin Infect Dis. 2023;77(5):672\u20139. https:\/\/doi.org\/10.1093\/cid\/ciad119.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2364_CR124","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.amjmed.2021.10.007","volume":"135","author":"N Wald-Dickler","year":"2022","unstructured":"Wald-Dickler N, Holtom PD, Phillips MC, Centor RM, Lee RA, Baden R, et al. Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review. Am J Med. 2022;135(3):369-79 e1. https:\/\/doi.org\/10.1016\/j.amjmed.2021.10.007.","journal-title":"Am J Med"},{"issue":"10","key":"2364_CR125","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","volume":"71","author":"LR Marks","year":"2020","unstructured":"Marks LR, Liang SY, Muthulingam D, Schwarz ES, Liss DB, Munigala S, et al. Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections. Clin Infect Dis. 2020;71(10):e650\u20136. https:\/\/doi.org\/10.1093\/cid\/ciaa365.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2364_CR126","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/cid\/ciac714","volume":"76","author":"JA Wildenthal","year":"2023","unstructured":"Wildenthal JA, Atkinson A, Lewis S, Sayood S, Nolan NS, Cabrera NL, et al. Outcomes of partial oral antibiotic treatment for complicated staphylococcus aureus bacteremia in people who inject drugs. Clin Infect Dis. 2023;76(3):487\u201396. https:\/\/doi.org\/10.1093\/cid\/ciac714.","journal-title":"Clin Infect Dis"},{"key":"2364_CR127","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae476","author":"A Mourad","year":"2024","unstructured":"Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC. Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials. Clin Infect Dis. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae476.","journal-title":"Clin Infect Dis"},{"issue":"14","key":"2364_CR128","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1161\/CIR.0000000000001090","volume":"146","author":"LM Baddour","year":"2022","unstructured":"Baddour LM, Weimer MB, Wurcel AG, McElhinney DB, Marks LR, Fanucchi LC, et al. Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association. Circulation. 2022;146(14):e187\u2013201. https:\/\/doi.org\/10.1161\/CIR.0000000000001090.","journal-title":"Circulation"},{"issue":"9","key":"2364_CR129","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jama.2025.4288","volume":"334","author":"SYC Tong","year":"2025","unstructured":"Tong SYC, Fowler VG Jr., Skalla L, Holland TL. Management of Staphylococcus aureus bacteremia: a review. JAMA. 2025;334(9):798\u2013808. https:\/\/doi.org\/10.1001\/jama.2025.4288.","journal-title":"JAMA"},{"issue":"5","key":"2364_CR130","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1808312","volume":"380","author":"K Iversen","year":"2019","unstructured":"Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med. 2019;380(5):415\u201324. https:\/\/doi.org\/10.1056\/NEJMoa1808312.","journal-title":"N Engl J Med"},{"issue":"5","key":"2364_CR131","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","volume":"380","author":"HK Li","year":"2019","unstructured":"Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med. 2019;380(5):425\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1710926.","journal-title":"N Engl J Med"},{"key":"2364_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00756-9","author":"AJ Kaasch","year":"2024","unstructured":"Kaasch AJ, Lopez-Cortes LE, Rodriguez-Bano J, Cisneros JM, Dolores Navarro M, Fatkenheuer G, et al. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial. Lancet Infect Dis. 2024. https:\/\/doi.org\/10.1016\/S1473-3099(23)00756-9.","journal-title":"Lancet Infect Dis"},{"key":"2364_CR133","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.12543","author":"NA Turner","year":"2025","unstructured":"Turner NA, Hamasaki T, Doernberg SB, Lodise TP, King HA, Ghazaryan V, et al. Dalbavancin for treatment of Staphylococcus aureus bacteremia: the DOTS randomized clinical trial. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.12543.","journal-title":"JAMA"},{"issue":"3","key":"2364_CR134","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1377\/hlthaff.2018.05067","volume":"38","author":"LP Forsythe","year":"2019","unstructured":"Forsythe LP, Carman KL, Szydlowski V, Fayish L, Davidson L, Hickam DH, et al. Patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute. Health Aff (Millwood). 2019;38(3):359\u201367. https:\/\/doi.org\/10.1377\/hlthaff.2018.05067.","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"2364_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01202-2","volume":"22","author":"DE Banks","year":"2025","unstructured":"Banks DE, Paschke ME, Campbell KD, Bradshaw-Glenn DD, Ghonasgi R, Barr B, et al. CENTER-ing Black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes. Harm Reduct J. 2025;22(1):64. https:\/\/doi.org\/10.1186\/s12954-025-01202-2.","journal-title":"Harm Reduct J"},{"key":"2364_CR136","unstructured":"Lambert J. Study: 14 million lives could be lost due to Trump aid cuts. National Public Radio2025."},{"issue":"10500","key":"2364_CR137","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(25)01186-9","volume":"406","author":"DM Cavalcanti","year":"2030","unstructured":"Cavalcanti DM, de Oliveira Ferreira de Sales L, da Silva AF, Basterra EL, Pena D, Monti C, et al. Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis. Lancet. 2030;406(10500):283\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(25)01186-9.","journal-title":"Lancet"},{"key":"2364_CR138","unstructured":"Kaiser Family Foundation. The Ryan White HIV\/AIDS Program: The Basics. 2025."},{"key":"2364_CR139","unstructured":"Dawson L. Domestic HIV Funding in the White House FY2026 Budget Request. Kaiser Family Foundation."},{"key":"2364_CR140","unstructured":"Institute HaHP. Trump Budget Ends All CDC HIV Prevention Programs, While Maintaining Care, Treatment, and PrEP. 2025."},{"key":"2364_CR141","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-25-01737","author":"R Forster","year":"2025","unstructured":"Forster R, Schnure M, Jones J, Lesko C, Batey DS, Butler I, et al. The potential impact of ending the Ryan White HIV\/AIDS program on HIV incidence: a simulation study in 31 U.S. cities. Ann Intern Med. 2025. https:\/\/doi.org\/10.7326\/ANNALS-25-01737.","journal-title":"Ann Intern Med"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02364-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02364-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02364-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:05:47Z","timestamp":1793001947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02364-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,4]]},"references-count":141,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2364"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02364-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,4]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the last 3 years, MRL has been a research consultant for Braeburn Pharmaceuticals, Berkshire Biomedical, and Journey Colab and has received an honorarium from Camurus for developing and giving a research talk about long-acting injectable buprenorphine. EE has received honoraria from PRIME and Integritas for developing continuing medical education content.\u00a0LF has been a consultant for Eli Lilly for development of medical education content unrelated to this manuscript.\u00a0","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Availability of Data And Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LCF: conceptualization, writing\u2014original draft, writing\u2014review and editing, project administration; EE: writing\u2014original draft, writing\u2014review and editing; NVS: writing\u2014original draft, writing\u2014review and editing; MRL: conceptualization, writing\u2014original draft, writing\u2014review and editing. All authors approved of the final manuscript for submission.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}